Effects of T'ai Chi on Serotonin, Nicotine Dependency, Depression, and Anger in Hospitalized Alcohol-Dependent Patients.

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

The aim of this study was to investigate the effects of t'ai chi on blood serotonin levels, nicotine dependence, depression, and anger in hospitalized alcohol-dependent patients.

Who Took Part

The study group was 19 patients.

PubMed indexes the participants as adults and middle-aged adults.

This study followed an experimental and nonequivalent control group in a non-synchronized design.

Thirty-eight patients who were hospitalized with alcohol dependence were included.

How the Study Was Run

In design terms this was a randomized study.

Random assignment meant chance, not the researchers, decided who got Therapeutic nicotine (patch, non-peptide) and who got the comparison, which limits bias.

It was performed in a hospital located in Young Ju city, Korea, from April to August 2013.

They were randomly divided into an experimental and a control group, with 19 patients in each group.

The effect of treatment was measured using blood serotonin levels and a questionnaire on nicotine dependence, depression, and anger.

Data were analyzed using the t-test, chi-square test, and paired t-tests.

What Was Measured

PubMed files the paper under topics including Alcoholism, Anger, Depression, Hospitalization, Nicotine, Serotonin and Smoking.

The authors tagged it with the keywords T'ai chi and nicotine dependence.

What This Means in Plain Language

The paper is a randomized study of Therapeutic nicotine (patch, non-peptide) in 19 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 2 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2016 (Journal of alternative and complementary medicine (New York, N.Y.)), a journal based in United States.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.